-
May 5, 2023, 16:29 PM
by
The latest version of FreeLIMS, a Laboratory Information Management System (LIMS), offers a comprehensive suite of features to digitally transform labs and meet compliance.
Full story
-
May 5, 2023, 16:29 PM
by
Nasdaq First North-listed Qlucore, leading software provider of visualization-based software for research-oriented data analysis and precision diagnostics, has launched Qlucore Omics Explorer (QOE) version 3.9. The new version provides statistical test results up to 900 times faster.
Full story
-
May 5, 2023, 16:29 PM
by
AARDEX Group Partners with Industry Leaders on DiMe’s V3+ Framework Project to Enhance Usability of DHTs
Extending the Verification, Analytical Validation, and Clinical Validation (V3+) Framework Project will ensure digital clinical measures and products meet the needs of larger audiences.
Full story
-
May 5, 2023, 16:29 PM
by
Clearwater today launched a new website and brand identity to reflect the company’s mission of serving the needs of the entire healthcare ecosystem following its acquisitions of TECH LOCK and CynergisTek.
It’s no secret that healthcare organizations need a strong cybersecurity and compliance partner now more than ever, and the combined company provides a deep pool of experts across a broad range of cybersecurity, privacy, and compliance domains.
Full story
-
May 5, 2023, 16:29 PM
by
CluePoints Supports Launch of RBQM Live 2023 as Premier Event Sponsor
Registration for must-attend Risk-Based Quality Management event is now open
Full story
-
May 5, 2023, 16:29 PM
by
Arranta Bio, part of Recipharm’s biologics business, has signed a contract with MIT to develop a continuous manufacturing technology for mRNA therapeutics.
Full story
-
May 5, 2023, 16:29 PM
by
Prestigious International Annual Awards Program Recognizes Standout Digital Health & Medical Technology Products and Companies
Full story
-
May 5, 2023, 16:29 PM
by
MultiOmic Health, an artificial intelligence (AI)-enabled drug discovery company, has closed a £5 million (US$6.2 million) seed funding extension round to build its precision therapeutics discovery platform for metabolic syndrome-related medical conditions.
Full story
-
May 5, 2023, 16:29 PM
by
The RSA Group, a leading life sciences executive search firm, has published the latest of its Talent Equity® Reports: No turning back – an analysis of the hybrid working models that have emerged from the pandemic and how they have enabled positive changes to leadership, team dynamics and recruitment and retention of talent in the life science sector.
Full story
-
May 5, 2023, 16:29 PM
by
FDB Vela™ Leader to Share Vision for Vastly Reducing Fill Times for Specialty Drug ePrescribing at NCPDP Annual Conference
Full story
-
May 5, 2023, 16:29 PM
by
BOC Sciences, one of the front-runners in chemical material manufacturing and custom services for the full drug product lifecycle, today reported strong growth over the past year in its expanded contract development and manufacturing (CDMO) platform.
Full story
-
May 5, 2023, 16:29 PM
by
BOC Sciences' radiochemists work closely with the worldwide drug compound research teams to deliver high-quality stable isotope labeled products as well as consulting and tailor-made services.
Full story
-
May 5, 2023, 01:00 AM
by
User Not Found
Bio-IT World | Next-generation sequencing (NGS) has revolutionized molecular biology and served as a universal tool for many research avenues across the spectrum of biology. With the NGS market expanding, three key barriers—time, cost, and expertise—are holding back the potential of NGS and the full impact it could have on society, diagnostics, and precision medicine.
Full story
-
May 4, 2023, 13:24 PM
by
User Not Found
Bio-IT World | At Pfizer, AI plays a key role in every step of the drug discovery process, Anastasia Christianson, Global Head of AI, ML, Analytics, and Data at Pfizer, tells Bio-Team co-founder Stan Gloss on the latest episode of the Trends from the Trenches podcast. Christianson will be the opening keynote at the 2023 Bio-IT World Conference & Expo, May 16-18, 2023, in Boston.
Full story
-
May 3, 2023, 01:00 AM
by
User Not Found
Bio-IT World | Up to now, mouse avatars haven’t proven to be particularly good tools for forecasting treatment response in human cancer patients. But new models being generated by an international team of researchers are expected to be far more predictive of what is going to happen with different cohorts of clinical trial participants.
Full story
-
Apr 27, 2023, 01:00 AM
by
User Not Found
Bio-IT World | Ginkgo Bioworks acquires an adeno-associated virus capsid discovery and engineering platform; Oxford Nanopore Technologies and bioMérieux SA have teamed up bring nanopore sequencing to the infectious disease diagnostics market, and the emergency of Large Language Models ops. Plus, new products from Metabolon, Cytiva, Vizgen, Agilent, and more.
Full story
-
Apr 26, 2023, 01:00 AM
by
User Not Found
Bio-IT World | Research autopsies are nothing new—the use of post-mortem tissues for cancer research has been ongoing since the end of the nineteenth century—but the Cancer Research UK-sponsored PEACE (posthumous evaluation of advanced cancer environment) study stands apart by virtue of its scope and scale. The pan-cancer initiative intends to enroll 500 patients across the country in hopes of understanding cancer evolution, drug resistance and why patients die of their disease.
Full story
-
Apr 25, 2023, 11:39 AM
by
CSHL scientists have discovered that a protein called BRD8 goes out of control in glioblastoma, paralyzing P53. The discovery could help turn this deadly cancer into a treatable disease.
Full story
-
Apr 25, 2023, 11:39 AM
by
Full story
-
Apr 25, 2023, 11:39 AM
by
Full story